Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity was posted on November 14, 2008. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NON-Clinical ADME Studies

Closed
RFP-N01DA-9-8883Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institute on Drug Abuse is seeking proposals for a cost reimbursement contract to conduct nonclinical absorption, distribution, metabolism, and elimination studies to support medication development. The scope of work includes bioavailability, pharmacokinetic, mass balance, and tissue distribution studies, as well as toxicokinetics analysis and in vivo permeability evaluations. Additionally, the contractor must provide analytical services for metabolite structure identification and the development of sensitive assays using technologies such as HPLC, LC-MS, and GC-MS. Eligible offerors must adhere to FDA Good Laboratory Practices and NIH guidelines for the care of laboratory animals. Due to the nature of the research, mandatory requirements include a DEA Research Registration for Chemical Analysis or Schedules II to V, and the demonstrated ability to obtain registration for Schedule I controlled substances. The anticipated contract structure consists of a three-year base period with two twelve-month option periods and additional quantity options.

General Info

Agency

N/A

Contract Value

$2,480,027

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Type Changed

Presolicitation → Solicitation

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Tonya D AndersonContract Specialist
Kenneth E GoodlingContracting Officer

Full Description

Show more
The National Institute on Drug Abuse (NIDA) plans to solicit proposals to perform nonclinical absorption, distribution, metabolism and elimination (ADME) studies to support its medications development program. The nonclinical ADME studies for this requirement typically include bioavailability and pharmacokinetic studies, mass balance studies, tissue distribution studies, in vivo evaluation of permeability, in vitro and vivo metabolism studies, and toxicokinetics analysis of new potential medications. In addition, this requirement also involves analytical services which includes structure identification of major metabolites by mass spectrometry or nuclear magnetic resonance (NMR), and the development of sensitive and specific assays for a potential medication and its metabolites in biological matrices using methods such as high performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), liquid chromatography with tandem mass spectrometry (LC/MS/MS), gas chromatograph-mass spectrometry (GC-MS). To handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a DEA Research Registration for Chemical Analysis or Research Registration for Schedules II to V. Also, offerors must demonstrate the capability to obtain a DEA registration for Schedule I controlled substances. All offerors must be in compliance with the NIH guidelines on the care and use of laboratory animals and, the laboratory must be operated according to the FDA's Good Laboratory Practices Program. NIDA anticipates the award of one cost reimbursement contract for a period of 3-years with 2 twelve-month option periods. The contract will include additional quantity options as well. RFP No. N01DA-9-8883 will be available electronically on or about September 2, 2008. You can access the RFP through the FedBizOpps (URL: http://www.fedbizopps.gov) or through the NIDA website (URL: http://www.nida.nih.gov/RFP/RFPList.html). All information required for the submission of a proposal will be contained in or accessible through the RFP package. Response to the RFP will be due on or about November 3, 2008. NIDA will consider proposals submitted by any responsible offeror. Based upon market research, the Government is not using the policies contained in Part 12, Acquisition of Commercial Items, in its solicitation for the described supplies or services. However, interested persons may identify to the contracting officer their interest and capability to satisfy the Government's requirement with a commercial item within 15 days of this notice. This advertisement does not commit the Government to award a contract.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS